Mediplantex National Pharmaceutical JSC (HNX:MED)

Vietnam flag Vietnam · Delayed Price · Currency is VND
20,400
-2,100 (-9.33%)
At close: Jan 30, 2026
-21.54%
Market Cap 253.16B
Revenue (ttm) 367.08B
Net Income (ttm) 15.27B
Shares Out 12.41M
EPS (ttm) 1,231.00
PE Ratio 16.57
Forward PE n/a
Dividend 1,200.00 (5.88%)
Ex-Dividend Date Jul 16, 2025
Volume 100
Average Volume 2,738
Open 20,400
Previous Close 22,500
Day's Range 20,400 - 20,400
52-Week Range 20,400 - 28,600
Beta 0.01
RSI 35.61
Earnings Date Apr 17, 2026

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 328
Stock Exchange Hanoi Stock Exchange
Ticker Symbol MED
Full Company Profile

Financial Performance

In 2025, HNX:MED's revenue was 367.08 billion, a decrease of -17.16% compared to the previous year's 443.14 billion. Earnings were 15.27 billion, an increase of 0.16%.

Financial Statements

News

There is no news available yet.